By checking "I accept," I authorize Allergan, or any contracted third parties acting on its behalf, to install cookies on my browser to remember the information that I input, track how I use sections of websites, enable Allergan to remember my user custom preferences, and to tailor my access to the website per my preferences.
Explore Our Company About AbbVie Strategy At a Glance Recognition Positions and Views All Stories Our Science Explore Our Science Technologies & Platforms Clinical Trials Products Therapeutic Focus Areas AbbVie Medical Information Services opens in a new window Community Explore Community Patient Associations IBD Scholarship Program Responsibility Explore Responsibility Voluntary Disclosure of Payments opens in a new window Grants and Donations FAQs about Grants and Donations and Journal Clubs and Rounds op
AbbVie's EPKINLY™ (epcoritamab injection/epcoritamab for injection) receives Health Canada authorization with conditions as the first and only subcutaneous bispecific antibody to treat adult patients with relapsed or refractory diffuse large b-cell lymphoma (DLBCL)
Links to allergan.ca (19)
torontocaricatures.comToronto Caricatures - Caricature Artists, Toronto Caricature Artist Illustrators and Entertainers in Toronto and surrounding are
torontodigitalcaricatures.comToronto Caricatures - Caricature Artists, Toronto Caricature Artist Illustrators and Entertainers in Toronto and surrounding are
csaps.caCSAPS | Canadian Society for Aesthetic Plastic Surgery
Toronto Caricatures - Caricature Artists, Toronto Caricature Artist Illustrators and Entertainers in Toronto and surrounding are